Search - tctmd.com

Displaying 61 - 80 of 259

Sort: Relevancy | Date

Case Presentation: ECMO-Assisted TAVR

Presentation TCT 2018

Case Presentation: ECMO-Assisted TAVR

Presenter: Bagrat Alekyan, Juan F. Granada, Vladimir Ganyukov, Samir R. Kapadia, Zaza Kavteladze, Roxana Mehran, Jeffrey W. Moses, Alex Nikanorov, Roman Tarasov, Narek Zakarian

September 22, 2018

Case Presentation: Complex Left Main and Retrograde Right Coronary Recanalization Procedure

Presentation TCT 2018

Case Presentation: Complex Left Main and Retrograde Right Coronary Recanalization Procedure

Presenter: Bagrat Alekyan, Juan F. Granada, Vladimir Ganyukov, Samir R. Kapadia, Zaza Kavteladze, Roxana Mehran, Jeffrey W. Moses, Alex Nikanorov, Roman Tarasov, Narek Zakarian

September 22, 2018

Antithrombotic therapy in patients with non-valvular atrial fibrillation undergoing PCI: "Dual Therapy is the right choice”

Presentation JIM 2018

Antithrombotic therapy in patients with non-valvular atrial fibrillation undergoing PCI: "Dual Therapy is the right choice”

Presenter: Roxana Mehran

February 23, 2018

COMBO Plus EPC Capture DES: Proven concept to hard clinical evidence

Presentation JIM 2018

COMBO Plus EPC Capture DES: Proven Concept to Hard Clinical Evidence

Presenter: Roxana Mehran

February 22, 2018

When and Which Antiplatelet Agent Should Be Dropped When Using Oral Anticoagulant Therapy?

Presentation TCT 2017

When and Which Antiplatelet Agent Should Be Dropped When Using Oral Anticoagulant Therapy?

Presenter: Robert A. Harrington, Kurt Huber, Roxana Mehran

November 01, 2017

Acute Kidney Injury As a PCI Quality Improvement Metric: Strengths and Weaknesses

Presentation TCT 2017

Acute Kidney Injury As a PCI Quality Improvement Metric: Strengths and Weaknesses

Presenter: Somjot S. Brar, Roxana Mehran, Hitinder S. Gurm

November 01, 2017

Acute Kidney Injury After TAVR: Frequency, Etiology, and Prevention

Presentation TCT 2017

Acute Kidney Injury After TAVR: Frequency, Etiology, and Prevention

Presenter: Somjot S. Brar, Roxana Mehran, Ran Kornowski

November 01, 2017

Acute Kidney Injury After PCI vs CABG: Which Is Preferred in the CKD Patient??

Presentation TCT 2017

Acute Kidney Injury After PCI vs CABG: Which Is Preferred in the CKD Patient??

Presenter: Somjot S. Brar, Roxana Mehran, Anand Prasad

November 01, 2017

Acute Kidney Injury in Cardiogenic Shock: Impact of Hemodynamic Support

Presentation TCT 2017

Acute Kidney Injury in Cardiogenic Shock: Impact of Hemodynamic Support

Presenter: Somjot S. Brar, Roxana Mehran, Michael P. Flaherty

November 01, 2017

Contrast Reduction Strategies in the Patient With CKD

Presentation TCT 2017

Contrast Reduction Strategies in the Patient With CKD

Presenter: Patricia J. Best, Somjot S. Brar, Roxana Mehran

November 01, 2017

Strategies to Increase Enrollment of Women and Minorities Into Clinical Trials

Presentation TCT 2017

Strategies to Increase Enrollment of Women and Minorities Into Clinical Trials

Presenter: David P. Faxon, Cindy L. Grines, Roxana Mehran

October 31, 2017

The Combo Stent: From Concept to Clinical Performance

Presentation TCT 2017

The Combo Stent: From Concept to Clinical Performance

Presenter: Manel Sabate, Joanna J. Wykrzykowska, Roxana Mehran

October 31, 2017

Featured Lecture: The NIH Mission to Enhance DIVERSITY in Clinical Trials, Education, and the Workforce

Presentation TCT 2017

Featured Lecture: The NIH Mission to Enhance DIVERSITY in Clinical Trials, Education, and the Workforce

Presenter: Roxana Mehran, George A. Mensah

October 31, 2017

Featured Lecture: Disparities Among Healthcare Providers and Optimal Cardiovascular Care Pathways in Underserved Populations - Realities and Solutions

Presentation TCT 2017

Featured Lecture: Disparities Among Healthcare Providers and Optimal Cardiovascular Care Pathways in Underserved Populations - Realities and Solutions

Presenter: Roxana Mehran, George A. Mensah, Cheryl Pegus

October 31, 2017

Rationale and Studies of P2Y12 Inhibitor Monotherapy

Presentation TCT 2017

Rationale and Studies of P2Y12 Inhibitor Monotherapy

Presenter: Dominick J. Angiolillo, Marco Valgimigli, Roxana Mehran

October 30, 2017

Diversity in Clinical Trials (Lessons Learned, Future Directions): Inclusion of Women

Presentation TCT 2017

Diversity in Clinical Trials (Lessons Learned, Future Directions): Inclusion of Women

Presenter: Wayne B. Batchelor, George A. Mensah, Roxana Mehran

October 30, 2017

Influence of Diversity: Should Sex, Race, and Ethnicity Affect Revascularization Decisions? Does It?

Presentation TCT 2017

Influence of Diversity: Should Sex, Race, and Ethnicity Affect Revascularization Decisions? Does It?

Presenter: Dean J. Kereiakes, Spencer B. King III, Roxana Mehran

October 30, 2017

Strengths and Limitations of Composite Endpoints (eg, EXCEL, PLATO, and Others)

Presentation TCT 2017

Strengths and Limitations of Composite Endpoints (eg, EXCEL, PLATO, and Others)

Presenter: Roxana Mehran, Robert W. Yeh, Stuart J. Pocock

October 30, 2017

How to Interpret Trials That Are Stopped Early (eg, PRAMI, FAME II, DECISION CTO, and Others)

Presentation TCT 2017

How to Interpret Trials That Are Stopped Early (eg, PRAMI, FAME II, DECISION CTO, and Others)

Presenter: Roxana Mehran, Robert W. Yeh, Laura Mauri

October 30, 2017

How to Interpret Noninferiority Trials (eg, ABSORB III, EVEREST II, and Others)

Presentation TCT 2017

How to Interpret Noninferiority Trials (eg, ABSORB III, EVEREST II, and Others)

Presenter: Roxana Mehran, Robert W. Yeh, Sanjay Kaul

October 30, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.